Business
Danaher CEO to Comment on Financial Performance
Danaher Corporation (NYSE: DHR) (the "Company") announced that its President and Chief Executive Officer, Rainer M. Blair, will comment tomorrow on the Company's fourth quarter 2025 performance in a presentation at the J.P. Morgan Healthcare Conference at 11:15 a.m. PT.
About this update from Danaher Corporation
[{"type":"text","content":"WASHINGTON, Jan. 12, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") announced that its President and Chief Executive Officer, Rainer M. Blair, will comment tomorrow on the Company's fourth quarter 2025 performance in a presentation at the J.P. Morgan Healthcare Conference at 11:15 a.m. PT.","length":326,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"For the fourth quarter 2025, estimated revenues are anticipated to increase in the mid-single digit percent range year-over-year.","length":129,"tagName":"p"}]},{"val":[{"type":"text","content":"Estimated non-GAAP core revenue growth for the fourth quarter of 2025 is expected to be toward the high-end of our previously announced low-single digit percentage guidance.","length":173,"tagName":"p"}]},{"val":[{"type":"text","content":"For the full year 2025, anticipated non-GAAP adjusted diluted net earnings per common share is expected to be toward the high-end of our previously announced guidance range of $7.70 to $7.80.","length":191,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":493,"olType":false},{"type":"text","content":"Rainer M. Blair, President and Chief Executive Officer, stated, "Our team executed well to deliver a solid finish to 2025. We were especially pleased with continued strength in Bioprocessing and better-than-expected Life Sciences and Diagnostics revenue in the fourth quarter."","length":287,"tagName":"p"},{"type":"text","content":"Mr. Blair continued, "We believe the combination of our differentiated portfolio, the power of the Danaher Business System and the strength of our balance sheet position Danaher for long-term value creation as we move into 2026 and beyond."","length":250,"tagName":"p"},{"type":"text","content":"The event will be simultaneously webcast and can be accessed on the "Investors" section of Danaher's website, www.danaher.com, under the subheading "Events & Presentations."","length":201,"tagName":"p"},{"type":"text","content":"As previously announced, Danaher will hold its quarterly earnings conference call for the fourth quarter and full year 2025 on Wednesday, January 28, 2026 at 8:00 a.m. ET.","length":171,"tagName":"p"},{"type":"text","content":"ABOUT DANAHER","length":13,"tagName":"p"},{"type":"text","content":"Danaher...